ABT vs RFL · P/E 25, rev $44.33B vs rev $30.0K
Abbott Laboratories (ABT) versus Rafael Holdings, Inc. (RFL) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Rafael Holdings, Inc. (RFL) is a real estate services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported RFL revenue for 2025-07-31 was $30.0K. Net income was -$30.6M. RFL currently screens at market cap $66.3M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. RFL currently screens at market cap $66.3M.
Not investment advice. Open the ABT and RFL stock pages for the full models.
Not investment advice.